Atlas Trials

Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets

Clinical trial NCT01672788 · COMPLETED

Trial details

NCT number
NCT01672788
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2012-08-01
Primary completion
2012-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.